× ×ª×× × ×ª×¨×פ×
××רש×
| ××× ×× ×× × ×ספ××
|
|
| ק×××¦× ×¤×¨×ק×××××ת (ATC4)
|
B01AF
Direct factor Xa inhibitors
|
| ×ר××× ×¤×¢×× (ATC5)
|
Â
|
| צ×רת ×ת×
|
פ××× - PER OS
|
| צ×רת ××× ××
|
×××××ת ×צ×פ×ת פ×××, FILM COATED TABLETS
××× ×עת ××× ×× ×תר ×× ×רע×× ×ש ××××× ×ת ×תר××¤× ××ת×× ×××× ×× ××××××¥ ××¤× ×©××פ××¢ ××¢××× ×צר××
|
| ×ת××××
|
⢠Prevention of stroke and systemic embolism in adult patients with nonvalvular atrial fibrillation (NVAF) with one or more risk factors, such as congestive heart failure, hypertension, age ⥠75 years,diabetes mellitus, prior stroke or transient ischaemic attack (TIA).⢠Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent DVT and PE in adults
|
| × ×ª×× × ×ס×
|
ת×ר×× ××××× ×ס×
- 30/01/2020
|
×××××ת ×ס×
- תר××¤× ×××××ת ×ר×ש×× ×¢'× ×¨××¤× ××××× ×× ××××× ××רת
|
×ת×××× ×ס×
| ×ת×××× |
ת×ר×× ××××× |
ת××× ×§××× × |
Class Effect |
××¦× ×××× |
×ס×ס ×××××ת
|
| ×× ×עת ש××¥ ×תס×××£ ס×ס××× ×××××× ×¢× ×¤×¨×¤×ר ×¢×××ת ××× ×××× ×סת××ת ×-CHA2DS2 VASc score ××¢×¨× 2 ×××¢×× |
30/01/2020 |
×× ×××× ×× |
DABIGATRAN ETEXILATE, RIVAROXABAN, EDOXABAN, APIXABAN |
|
|
| ×× ×עת ש××¥ ×תס×××£ ס×ס××× ×××××× ×¢× ×¤×¨×¤×ר ×¢×××ת ××××פ××× ×-Warfarin ×שת××¢× ×צ×× INR ×××× ×-5 ×פ××ת פע×××× ××××× ××©× × ×××ר×× × ×××ר××¢×× × ×¤×¨××× |
30/01/2020 |
×× ×××× ×× |
DABIGATRAN ETEXILATE, RIVAROXABAN, EDOXABAN, APIXABAN |
|
|
| ×× ×עת ש××¥ ×תס×××£ ס×ס××× ×××××× ×¢× ×¤×¨×¤×ר ×¢×××ת ××××פ××× ×-warfarin ×××× CVA ×× TIA ×¢× ××××× ×§××× × (ש×××¤× ×× ××××× ×××ת ×××××) ××××× ××©× × ×××ר×× × |
30/01/2020 |
×× ×××× ×× |
DABIGATRAN ETEXILATE, RIVAROXABAN, EDOXABAN, APIXABAN |
|
|
| ××פ×× ×§×¦×¨ ×××× ××× ×עת ש××¥ ×תס×××£ ס×ס××× ×××××× ×¢× ×¤×¨×¤×ר ×¢×××ת ××× ×××× ×סת××ת ×-CHADS2 score ××¢×¨× 0 ×× 1 ×××¨× ××פ×× ×§×¦× ×פע×××ת ×©× ×××צ××ת ×פרפ×ר |
30/01/2020 |
×× ×××× ×× |
DABIGATRAN ETEXILATE, RIVAROXABAN, EDOXABAN, APIXABAN |
|
|
| ××פ×× ××× ××¢× ×©× ××× ×ת ×©× ×ª×¡×××£ ר×××ª× (Pulmonary embolism - PE). |
30/01/2020 |
×× ×××× ×× |
DABIGATRAN ETEXILATE, RIVAROXABAN, EDOXABAN, APIXABAN |
Pulmonary embolism, PE |
|
| ××פ×× ××× ××¢× ×©× ××× ×ת ×©× ×¤×§×§×ª ××ר×××× ××¢××ק×× (Deep vein thrombosis â DVT). |
30/01/2020 |
×× ×××× ×× |
DABIGATRAN ETEXILATE, RIVAROXABAN, EDOXABAN, APIXABAN |
Deep vein thrombosis, DVT |
|
|
ש×××ש ×ס×
-
|
×ס×רת ××××× ×ס×
- ×תר××¤× ×ª×× ×ª× ×××פ×× ××קר×× ××××:
- 1. ×× ×עת ש××¥ ×תס×××£ ס×ס××× ×××××× ×¢× ×¤×¨×¤×ר ×¢×××ת ××××פ××× ×-warfarin ×××× CVA ×× TIA ×¢× ××××× ×§××× × (ש×××¤× ×× ××××× ×××ת ×××××) ××××× ××©× × ×××ר×× ×.
- 2. ×× ×עת ש××¥ ×תס×××£ ס×ס××× ×××××× ×¢× ×¤×¨×¤×ר ×¢×××ת ××××פ××× ×-Warfarin ×שת××¢× ×צ×× INR ×××× ×-5 ×פ××ת פע×××× ××××× ××©× × ×××ר×× × ×××ר××¢×× × ×¤×¨×××.
- 3. ×× ×עת ש××¥ ×תס×××£ ס×ס××× ×××××× ×¢× ×¤×¨×¤×ר ×¢×××ת ××× ×××× ×סת××ת ×-CHA2DS2 VASc score ××¢×¨× 2 ×××¢××.
- 4. ××פ×× ×§×¦×¨ ×××× ××× ×עת ש××¥ ×תס×××£ ס×ס××× ×××××× ×¢× ×¤×¨×¤×ר ×¢×××ת ××× ×××× ×סת××ת ×-CHADS2 score ××¢×¨× 0 ×× 1 ×××¨× ××פ×× ×§×¦× ×פע×××ת ×©× ×××צ××ת ×פרפ×ר.
- 5. ××פ×× ××× ××¢× ×©× ××× ×ת ×©× ×¤×§×§×ª ××ר×××× ××¢××ק×× (Deep vein thrombosis â DVT).
- 6. ××פ×× ××× ××¢× ×©× ××× ×ת ×©× ×ª×¡×××£ ר×××ª× (Pulmonary embolism - PE).
|
|
| ×¢××× ×ר××¤× ××××ר×ת ××¢×××
|
Â
Â
|
| ××פ×ש ×××ר××
|
×××ר×× ×-PubMed
|
| ××××¢ ×רשת
|
RxList WebMD Drugs.com
|
| ×©× ×צר×
|
DAIICHI SANKYO EUROPE GMBH
|
| ×©× ××¢× ×ר×ש××
|
MEDISON PHARMA LTD
|
| ר×ש×××
|
ת×ר×× ××ש×: 3/2019. ר×ש××× ×ת×ר××:
|
| ת×ר×× ×¢×××× ××ר××
|
03/09/2024
|
ת×ר×× ×¢××××: 03/09/2024
DAIICHI
××קס××× × - Lixiana
true
×××ר××
×צפ××× ×××××¢ ××ר×× ×ר×פ××× ×ש
××××× ×¡ ××ש××× ×. ×× ××× × ×¨×©×× ××× ×¡ ×
×רש×× ×ר×פ××× ××× ×©× ×קצ××¢×ת רפ×××××.
השינוי האחרון נעשה בֹ־9 בפברואר 2025 ב־04:43
